AI assistant
Sending…
CStone Pharmaceuticals — Director's Dealing 2022
Aug 30, 2022
50715_rns_2022-08-30_5a722e46-4f4e-4a11-9794-29007fab8f0a.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [173 x 58] intentionally omitted <==
Public Disclosure Form
30 August 2022
Possible offer
Disclosure of dealings in the shares of Yankuang Energy Group Company Limited
The Executive received the following disclosure of securities dealings pursuant to Rule 22 of the Hong Kong Code on Takeovers and Mergers:
| Party | Date | Description | Nature of dealings | Purchase | Total | Total amount | Highest (H) | Lowest (L) |
|---|---|---|---|---|---|---|---|---|
| of relevant | / Sale | number of | paid / received | prices paid | prices paid | |||
| securities | shares | / received | / received | |||||
| involved | ||||||||
| China International | 29 August | Ordinary | Hedging as a result of the | Purchase | 2,100 | $102,475.0000 | $48.7976 | $48.7976 |
| Capital Corporation | 2022 | shares | creation of new index-tracking | |||||
| Limited | ETFs where the relevant | |||||||
| securities represent less than | ||||||||
| 1% of the class in issue and | ||||||||
| less than 20% of the value of | ||||||||
| the securities in the basket or | ||||||||
| index |
Public Disclosure Form
==> picture [71 x 43] intentionally omitted <==
| Ordinaryshares | Disposal of the underlyingshares received from theredemption of pre-existingindex-tracking ETFs as aresult of unsolicited clientrequests | Sale | 2,100 | $108,255.0000 | $51.5500 | $51.5500 |
|---|
End
Note:
China International Capital Corporation Limited is an exempt principal trader connected with the Offeror. Dealings were made for its own account.
The shares reported refer to A shares of Yankuang Energy Group Company Limited (600188.SH), and price per unit is in RMB.
More from CStone Pharmaceuticals
Transaction in Own Shares
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 27
Annual Report
2026
Apr 27
Share Issue/Capital Change
2026
Apr 23
Share Issue/Capital Change
2026
Apr 22
Share Issue/Capital Change
2026
Apr 22
Regulatory Filings
2026
Apr 22
Regulatory Filings
2026
Apr 20